Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

86 results about "6-Aminocaproic Acid" patented technology

Synthesis method of specific salbutamol artificial antigen

The invention discloses a synthesis method of a specific salbutamol artificial antigen, belonging to the technical field of biological chemical engineering. The synthesis method disclosed by the invention comprises the following steps of: activating salbutamol through a formaldehyde solution, and connecting 6-aminocaproic acid in the ortho-position of a phenolic hydroxyl group to obtain a salbutamol hapten; and coupling a carboxyl group on the salbutamol hapten with an amino group on a carrier protein to obtain the salbutamol artificial antigen. The synthesis method disclosed by the invention can make up for the insufficiencies and defects of the existing salbutamol antigen synthesis technologies, the salbutamol artificial antigen with high specificity is obtained, the specificity of a produced antibody is high, and the sensitivity is high; and experimental results show that the antiserum titre of an animal immunized by using the salbutamol artificial antigen disclosed by the invention can achieve 80000, the detection limit is 0.5ng / mL, and the half-inhibitory concentration IC50 is 5ng / mL. The antigen or the antibody disclosed by the invention can be used for establishing an enzyme-linked immunosorbent analytical method and a colloidal gold test strip rapid assay method so as to rapidly detect the residues of the salbutamol in a food and further realize broad application prospects.
Owner:JIANGNAN UNIV

Preparation method of 6-aminocaproic acid

The invention discloses a preparation method of 6-aminocaproic acid. The 6-aminocaproic acid is obtained by using caprolactam as a raw material through alkali hydrolysis, neutralization processing, desalination processing and refining processing; alkali hydrolysis is that the caprolactam reacts with sodium hydroxide and water for 1 to 5h at a temperature of 100 to 110 DEG C; neutralization processing is that the material obtained after alkali hydrolysis is cooled to room temperature and is neutralized into pH of 7.5 by dilute sulphuric acid; desalination processing is that the material obtained after neutralization processing is subjected to desalination of electrodialysis. According to the method disclosed by the invention, an alkali hydrolysis method is adopted, then the dilute sulphuricacid is adopted to neutralize the material obtained after alkali hydrolysis into an isoelectric point of the 6-aminocaproic acid, and electrodialysis is utilized to desalinate. The method not only isconvenient to operate and simple in reaction condition, but also does not need to adopt ion exchange resin so as to greatly reduce the defects of higher production cost, serious pollution to the environment and the like of a resin absorption method; particularly, the method is higher in yield, is basically 95% or more and is suitable for industrial mass production.
Owner:CHANGZHOU LANLING PHARMA

Synthesis method of highly specific folic acid complete antigen and application of folic acid complete antigen

The invention relates to a synthesis method of a highly specific folic acid complete antigen and an application of the folic acid complete antigen and belongs to the technical field of biochemical industry. The synthesis method disclosed by the invention comprises the steps of adding 6-aminocaproic acid and water-soluble carbodiimide into a vector protein solution and then reacting at a room temperature and carrying out dialysis to obtain a vector protein B modified by a linker arm, dissolving folic acid(N-{4-[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methylamino]benzoyl}-L-glutamic acid) in dimethyl sulfoxide, adding dicyclohexyl carbodiimide and hydroxysuccinimide, reacting to obtain a folic acid derivative and then coupling the folic acid derivative with an amino group on the linker arm of the vector protein B to obtain the complete antigen. The results show that the titer of the antiserum obtained by immunizing animals with the antigen disclosed by the invention reaches up to 81000, the detection limit is 0.042ng/mL, and the half-inhibitory concentration is 0.3ng/mL. The produced antibody has high specificity and high sensitivity. The antigen or antibody disclosed by the invention is used for preparing an immunoaffinity column, establishing an enzyme linked immunosorbent assay method and colloidal gold strip rapid detection method and detecting the residue of folic acid.
Owner:JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products